Amneal Pharmaceuticals Inc (AMRX): Margin operasi

Logo perusahaan publik Amneal Pharmaceuticals, Inc. (AMRX)

Scaling risks for Amneal Pharmaceuticals (AMRX) are linked to a dependence on plant automation and the breadth of its product portfolio. Tracking the operating margin confirms the business's resilience, where 16.40 represents the current value of the metric. Stability is underpinned by a reputation as a reliable supplier of high-quality biosimilars, while steady cash flow is guaranteed by the inertia of high demand for affordable generics, eliminating any signs of declining operational activity.

Amneal Pharmaceuticals, Inc. (AMRX): Rentabilitas operasi saka 04.07.2022 nganti 20.11.2026

Amneal Pharmaceuticals (AMRX) - rincian metrik lan laporan keuangan

- rega saham lan konsensus proyeksi valuasi:
Pambiji fundamental perusahaan:Amneal Pharmaceuticals, Inc., AMRX
Barang utama Amneal Corp

The financial stability of Amneal Pharmaceuticals (AMRX) is based on the flawless trust of distributors in generic supplies, which minimizes operational risks. By analyzing the core business margin, an investor assesses the share of operating profit in total revenue before taxes and interest, determining cost management efficiency and the fundamental evolution of business profitability through the price action on this chart.

Pesaing utama

Rentabilitas operasi haleon.com|Rentabilitas operasi KVUE|Rentabilitas operasi Verona Pharma (VRNA)|Jyong Biotech (MENS) - Tingkat bathi adhedhasar bathi operasi|Margin operasi LGND (Ligand Pharma)|Tingkat bathi adhedhasar bathi operasi Perrigo Company PLC|Alvotech Biopharmaceuticals - Margin operasi|Rentabilitas kegiatan operasi Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Rentabilitas operasi|anipharmaceuticals.com - Tingkat bathi operasi|Margin dodolan operasi MNKD|AMPH: Tingkat bathi operasi|Rentabilitas operasi pacira.com (PCRX)|Margin operasi ARS Pharma (SPRY)|Theravance Biopharma - Margin dodolan operasi|Rasio bathi operasi AQST (Aquestive Therapeutics)|SCPH: Margin dodolan operasi|Rentabilitas dodolan operasi Tectonic Therapeutic|TNXP: Margin operasi|SXT China (SXTC) - Margin operasi|Rentabilitas operasi eupraxiapharma.com|BioHarvest Sciences (BHST) - Rentabilitas kegiatan operasi|Rentabilitas operasi Invizyne (EXOZ)|ORMP - Rentabilitas dodolan operasi|Margin operasi ENTX (Entera Bio)|Tingkat bathi adhedhasar bathi operasi MindWalk Therapeutics|ABVC: Margin dodolan operasi|CPIX - Margin operasi|QNTM (Quantum BioPharma) - Margin dodolan operasi|Margin bathi operasi FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Margin operasi|Margin operasi ranitherapeutics.com|Rentabilitas operasi Synergy CHC Corp. (SNYR)|Rallybio Corp - Rentabilitas dodolan miturut bathi operasi|lexariabioscience.com - Margin dodolan operasi|Margin operasi Pulmatrix Inc PULM|Pheton Holdings - Margin operasi|Margin bathi operasi APM|Lyra Therapeutics, Inc. (LYRA) - Rentabilitas operasi|Rentabilitas dodolan operasi Impact BioMedical, Inc. (IBO)|Rentabilitas operasi TNF Pharma|YCBD: Tingkat bathi operasi|Margin operasi PRFX|CYTO - Rentabilitas dodolan operasi|Rentabilitas operasi Lipella LIPO|Rasio bathi operasi OPTN (OptiNose, Inc.)|PIRS - Rentabilitas operasi|Procaps (PROC) - Margin dodolan operasi|PTPI: Margin operasi|Qilian International (QLI) - Margin operasi|Rentabilitas operasi Acelyrin, Inc.|Margin operasi TFF Pharmaceuticals, Inc.